300 related articles for article (PubMed ID: 26283652)
1. Educational level and risk profile and risk control in patients with coronary heart disease.
Bruthans J; Mayer O; De Bacquer D; De Smedt D; Reiner Z; Kotseva K; Cífková R;
Eur J Prev Cardiol; 2016 May; 23(8):881-90. PubMed ID: 26283652
[TBL] [Abstract][Full Text] [Related]
2. Lifestyle behaviour and risk factor control in coronary patients: Belgian results from the cross-sectional EUROASPIRE surveys.
De Smedt D; De Sutter J; De Pauw M; Vandekerckhove H; Trouerbach J; De Backer G; Willems AM; Pardaens S; Vervaet P; Deweerdt N; De Bacquer D
Acta Cardiol; 2019 Feb; 74(1):21-27. PubMed ID: 29458303
[TBL] [Abstract][Full Text] [Related]
3. Educational level and risk profile of cardiac patients in the EUROASPIRE II substudy.
Mayer O; Simon J; Heidrich J; Cokkinos DV; De Bacquer D;
J Epidemiol Community Health; 2004 Jan; 58(1):47-52. PubMed ID: 14684726
[TBL] [Abstract][Full Text] [Related]
4. Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) IV cross-sectional survey in 14 European regions.
Kotseva K; De Bacquer D; De Backer G; Rydén L; Jennings C; Gyberg V; Abreu A; Aguiar C; Conde AC; Davletov K; Dilic M; Dolzhenko M; Gaita D; Georgiev B; Gotcheva N; Lalic N; Laucevicius A; Lovic D; Mancas S; Miličić D; Oganov R; Pajak A; Pogosova N; Reiner Ž; Vulic D; Wood D; On Behalf Of The Euroaspire Investigators
Eur J Prev Cardiol; 2016 Dec; 23(18):2007-2018. PubMed ID: 27638542
[TBL] [Abstract][Full Text] [Related]
5. EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. EUROASPIRE Study Group. European Action on Secondary Prevention through Intervention to Reduce Events.
Eur Heart J; 1997 Oct; 18(10):1569-82. PubMed ID: 9347267
[TBL] [Abstract][Full Text] [Related]
6. The use of HeartQoL in patients with coronary heart disease: Association with risk factors and European reference values. The EUROASPIRE IV study of the European Society of Cardiology.
De Smedt D; Clays E; Höfer S; Oldridge N; Kotseva K; Maggioni AP; Pogosova N; Dolzhenko M; De Bacquer D
Eur J Prev Cardiol; 2016 Jul; 23(11):1174-86. PubMed ID: 26862122
[TBL] [Abstract][Full Text] [Related]
7. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries.
Kotseva K; Wood D; De Bacquer D; De Backer G; Rydén L; Jennings C; Gyberg V; Amouyel P; Bruthans J; Castro Conde A; Cífková R; Deckers JW; De Sutter J; Dilic M; Dolzhenko M; Erglis A; Fras Z; Gaita D; Gotcheva N; Goudevenos J; Heuschmann P; Laucevicius A; Lehto S; Lovic D; Miličić D; Moore D; Nicolaides E; Oganov R; Pajak A; Pogosova N; Reiner Z; Stagmo M; Störk S; Tokgözoğlu L; Vulic D;
Eur J Prev Cardiol; 2016 Apr; 23(6):636-48. PubMed ID: 25687109
[TBL] [Abstract][Full Text] [Related]
8. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events.
EUROASPIRE I and II Group; European Action on Secondary Prevention by Intervention to Reduce Events
Lancet; 2001 Mar; 357(9261):995-1001. PubMed ID: 11293642
[TBL] [Abstract][Full Text] [Related]
9. Time Trends in Lifestyle, Risk Factor Control, and Use of Evidence-Based Medications in Patients With Coronary Heart Disease in Europe: Results From 3 EUROASPIRE Surveys, 1999-2013.
Kotseva K; De Bacquer D; Jennings C; Gyberg V; De Backer G; Rydén L; Amouyel P; Bruthans J; Cifkova R; Deckers JW; De Sutter J; Fraz Z; Graham I; Keber I; Lehto S; Moore D; Pajak A; Wood D;
Glob Heart; 2017 Dec; 12(4):315-322.e3. PubMed ID: 26994643
[TBL] [Abstract][Full Text] [Related]
10. The gender gap in risk factor control: Effects of age and education on the control of cardiovascular risk factors in male and female coronary patients. The EUROASPIRE IV study by the European Society of Cardiology.
De Smedt D; De Bacquer D; De Sutter J; Dallongeville J; Gevaert S; De Backer G; Bruthans J; Kotseva K; Reiner Ž; Tokgözoğlu L; Clays E
Int J Cardiol; 2016 Apr; 209():284-90. PubMed ID: 26913370
[TBL] [Abstract][Full Text] [Related]
11. Blood pressure control and knowledge of target blood pressure in coronary patients across Europe: results from the EUROASPIRE III survey.
Prugger C; Keil U; Wellmann J; de Bacquer D; de Backer G; Ambrosio GB; Reiner Z; Gaita D; Wood D; Kotseva K; Heidrich J;
J Hypertens; 2011 Aug; 29(8):1641-8. PubMed ID: 21720270
[TBL] [Abstract][Full Text] [Related]
12. Secondary Prevention in Younger vs. Older Coronary Heart Disease Patients-Insights from the German Subset of the EUROASPIRE IV Survey.
Wagner M; Gelbrich G; Kircher J; Kotseva K; Wood D; Morbach C; Leyh R; Ertl G; Karmann W; Störk S; Heuschmann PU
Int J Behav Med; 2018 Jun; 25(3):283-293. PubMed ID: 29086252
[TBL] [Abstract][Full Text] [Related]
13. Control of main risk factors after ischaemic stroke across Europe: data from the stroke-specific module of the EUROASPIRE III survey.
Heuschmann PU; Kircher J; Nowe T; Dittrich R; Reiner Z; Cifkova R; Malojcic B; Mayer O; Bruthans J; Wloch-Kopec D; Prugger C; Heidrich J; Keil U
Eur J Prev Cardiol; 2015 Oct; 22(10):1354-62. PubMed ID: 25139770
[TBL] [Abstract][Full Text] [Related]
14. Health related quality of life in coronary patients and its association with their cardiovascular risk profile: results from the EUROASPIRE III survey.
De Smedt D; Clays E; Annemans L; Doyle F; Kotseva K; Pająk A; Prugger C; Jennings C; Wood D; De Bacquer D
Int J Cardiol; 2013 Sep; 168(2):898-903. PubMed ID: 23201081
[TBL] [Abstract][Full Text] [Related]
15. Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries--Findings from the EUROASPIRE IV survey.
Reiner Ž; De Backer G; Fras Z; Kotseva K; Tokgözoglu L; Wood D; De Bacquer D;
Atherosclerosis; 2016 Mar; 246():243-50. PubMed ID: 26812002
[TBL] [Abstract][Full Text] [Related]
16. The assessment of coronary heart disease risk factors correlated with demographic and social data in post-coronary intervention patients in Polish population.
Budnik M; Opolski G
Cardiol J; 2015; 22(3):276-84. PubMed ID: 26118382
[TBL] [Abstract][Full Text] [Related]
17. [Secondary prevention of coronary heart disease. Results from EuroASPIRE I and II in the region of Münster, Germany].
Heidrich J; Liese AD; Kalic M; Winter-Enbergs A; Wellmann J; Roeder N; Kerber S; Breithardt G; Scheld HH; Kleine-Katthöfer P; Keil U
Dtsch Med Wochenschr; 2002 Mar; 127(13):667-72. PubMed ID: 11928058
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries.
Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Keil U;
Lancet; 2009 Mar; 373(9667):929-40. PubMed ID: 19286092
[TBL] [Abstract][Full Text] [Related]
19. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study).
Reiner Z; Mihatov S; Milicić D; Bergovec M; Planinc D;
Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):646-54. PubMed ID: 16874158
[TBL] [Abstract][Full Text] [Related]
20. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme.
EUROASPIRE II Study Group
Eur Heart J; 2001 Apr; 22(7):554-72. PubMed ID: 11259143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
